Back to results
US 2016/0263210 A1Published application
Live attenuated infectious laryngotracheitis virus (iltv) vaccines and preparation thereof
AssigneeUniversity of Delaware
InventorsJack Gelb, JR., Brian S. Ladman, Miguel Ruano
Life of this patent
Estimating the term…
Abstract
This disclosure describes a modified live infectious laryngotracheitis virus (ILTV) developed from a strain of ILTV grown at a reduced incubation temperature, vaccines that include the modified live ILTV, methods for producing the live modified ILTV, and methods that include administering the modified ILTV to a subject.
Claims19
An attenuated infectious laryngotracheitis virus (ILTV) comprising:
- at least one genetic modification listed in Table 11.
(canceled)
A method of producing a live attenuated infectious laryngotracheitis virus (ILTV), the method comprising serially passaging the ILTV in culture at a temperature no greater than 35° C.
Dependencies are inferred from the claim text.